Recent Faculty Publications

Kristen L Woodhouse, Jun-Xu Li. (2025) Individual differences in behavioral effects of xylazine and opioid-xylazine mixtures in male rats. Psychopharmacology (Dec) doi:10.1007/s00213-025-06988-4
Kern KA, DiBrog AM, Demieri E, Przybysz JT, Clark SD, Mietlicki-Baase EG. (2025) Central pramlintide administration potently suppresses operant responding for sucrose and locomotor activity in male rats. Physiology & behavior (Dec), 302: 115114.
Kedari KG, Smith Z, Cheli VT, Corral JG, Wang C, Paez PM. (2025) Astrocyte-specific deletion of ceruloplasmin exacerbates oxidative stress and demyelination in the spinal cord in a murine model of multiple sclerosis. Neurobiology of disease (Dec)107249.
Cheli VT, Paez PM. (2025) Voltage-Gated and Chemogenetic Modulation of Calcium Signaling in Oligodendrocyte Development and Synaptic Integration. Journal of neurochemistry (Oct), 169(10): e70259.
Cheli VT, Wartanian TP, Santiago González DA, Corral JG, Angeliu CG, Tumuluri SG, Wang C, Smith Z, Paez PM. (2025) Chemogenetic Activation of Oligodendrocytes Delays Postnatal Myelination by Promoting Progenitor Proliferation and Inhibiting Maturation. Glia (Oct).
Cheli VT, Tumuluri SG, McDonald Z, Denton TT, Dupree JL, Paez PM, Feinstein DL. (2025) Lanthionine Ketimine Ethyl Ester Induces Proliferation and Maturation and Regulates Calcium Flux in Primary Mouse Oligodendrocyte Progenitor Cells. Journal of neuroscience research (Jul), 103(7): e70061.
Oubraim S, Fauzan M, Studholme K, Gordon C, Glaser ST, Shen RY, Ojima I, Kaczocha M, Haj-Dahmane S. (2025) Astrocytic FABP5 mediates retrograde endocannabinoid transport at central synapses. iScience (May), 28(5): 112342. doi:10.1016/j.isci.2025.112342
Bing Wang, Xiaozhou Feng, Kristen Woodhouse, Dilip Sharma, Xianglei Meng, Huijie Shang, Huijuan Hu, Dehui Zhang, Yanan Zhang, Jun-Xu Li, Yuan-Xiang Tao. (2025) Lysophosphatidic acid receptor 5 in insular cortex as a potential analgesic target in neuropathic pain. Neurotherapeutics (May) doi:10.1016/j.neurot.2025.e00609
Jeon S, Park J, Moon JH, Shin D, Li L, O'Shea H, Hwang SU, Lee HJ, Brimble E, Lee JW, Clark SD, Lee SK. (2025) The patient-specific mouse model with Foxg1 frameshift mutation provides insights into the pathophysiology of FOXG1 syndrome. Nature communications (May), 16(1): 4760.
Oubraim S, Hausknecht K, Micov V, Shen RY, Haj-Dahmane S. (2025) Chemogenetic inhibition of prefrontal cortex inputs to dorsal raphe reduces anxiety behaviors in male rat model of fetal alcohol spectrum disorder. Scientific reports (Apr), 15(1): 14397. doi:10.1038/s41598-025-99181-8
Lynn MB, Geddes SD, Chahrour M, Maillé S, Caya-Bissonnette L, Harkin E, Harvey-Girard É, Haj-Dahmane S, Naud R, Béïque JC. (2025) Nonlinear recurrent inhibition through facilitating serotonin release in the raphe. Nature neuroscience (Apr).
Thuy Nguyen, Ann M Decker, Daniel G Barrus, Chi Hyuck Song, Jianfeng Liu, Thomas F Gamage, Danni L Harris, Jun-Xu Li, Yanan Zhang. (2025) Development of Squaramides as Allosteric Modulators of the CB1 Receptor: Synthesis, Computational Studies, Biological Characterization, and Effects against Cocaine-Induced Behavioral Sensitization and Reinstatement in Rats. Journal of Medical Chemistry (Apr) doi:10.1021/acs.jmedchem.5c00383
Sharafshah A, Lewandrowski KU, Gold MS, Fuehrlein B, Ashford JW, Thanos PK, Wang GJ, Hanna C, Cadet JL, Gardner EL, Khalsa JH, Braverman ER, Baron D, Elman I, Dennen CA, Bowirrat A, Pinhasov A, Modestino EJ, Carney PR, Cortese R, Fiorelli RKA, Schmidt S, Pollack AR, Badgaiyan RD, Blum K. (2025) In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder. Current neuropharmacology (Jan).
Lu H, Roeder N, Richardson B, Hamilton J, Sharma A, Owada Y, Kagawa Y, Thanos P. (2025) Fatty acid-binding protein 7 gene deletion promotes decreases in brain cannabinoid type 1 receptor binding. Neuroscience letters (Jan), 844: 138040.
Finnell JE, Ferrario CR. (2025) Voluntary food restriction does not affect circulating corticosterone in obesity-prone or -resistant male and female rats. Physiology & behavior (Jan), 288: 114729.
Green RP, Blum K, Lewandrowski KU, Gold MS, Lewandrowski APL, Thanos PK, Dennen CA, Baron D, Elman I, Sharafshah A, Modestino EJ, Badgaiyan RD. (2025) Letter to the Editor. Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk. Substance abuse and rehabilitation (Jan), 16: 23-26. doi:10.2147/SAR.S514931
Sunder K, Makale MT, Makale M, Bodhanapati J, Murphy KT, Dennen CA, Baron D, Thanos PK, Hanna C, Ashford JW, Lewandrowski KU, Blum K. (2025) Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case Series. Psychology research and behavior management (Jan), 18: 225-240. doi:10.2147/PRBM.S482960
Wang R, Martin CD, Lei AL, Hausknecht KA, Richards JB, Haj-Dahmane S, Shen RY. (2025) Environmental enrichment reverses prenatal ethanol exposure-induced attention-deficits in rats. Frontiers in psychiatry (Jan), 16: 1549318. doi:10.3389/fpsyt.2025.1549318
McDonald Z, Tandon A, Denton TT, Taneja M, Rocha J, Dupree JL, Paez PM, Cheli VT, Tumuluri SG, Feinstein DL. (2025) Identifying Lanthionine Ketimine Derivatives for Maturation and Proliferative Effects in Oligodendrocyte Progenitor Cells. ASN neuro (Jan), 17(1): 2535963.
Blum K, Bowirrat A, Thanos PK, Hanna C, Khalsa J, Baron D, Elman I, Badgaiyan RD, Dennen C, Braverman ER, Carney P, Lewandrowski KU, Sharafshah A, Gold MS. (2024) Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction. EC psychology and psychiatry (Dec), 13(1): 1-3.